ATR
APTARGROUP, INC.
Company overview
- Market capitalization
- $7.91B
- Employees
- 14,000
- Latest publication
- 2026-09-29
About APTARGROUP, INC.
AptarGroup, Inc. designs and manufactures drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, fragrance, facial skincare, color cosmetics, personal care, home care, and food and beverage markets. The company operates through three segments: Pharma, Beauty, and Closures. It provides dispensing pumps used to dispense sprays, liquids, or lotions from non-pressurized containers; fine-mist pumps for pharmaceutical and fragrance applications; and lotion pumps for viscous formulations, as well as closures, such as dispensing and non-dispensing solutions that enable product delivery without removal of the cap and used across various consumer end markets. The company also offers aerosol valves used in pressurized containers and continuous spray and metered-dose valves for pharmaceutical, personal care, and household applications; elastomeric primary packaging components; active material science solutions; and digital health solutions. The company primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,026,508,000USD | 982,868,000USD | 962,736,000USD | 961,131,000USD | 966,009,000USD | 887,305,000USD | 848,088,000USD | 909,291,000USD |
| Cost Of Revenue | 660,991,000USD | 706,684,000USD | 701,093,000USD | 673,280,000USD | 668,898,000USD | 616,538,000USD | 518,674,000USD | 558,511,000USD |
| Gross Profit | 365,517,000USD | 276,184,000USD | 261,642,999USD | 287,851,000USD | 297,111,000USD | 270,767,000USD | 329,414,000USD | 350,780,000USD |
| Total Operating Expenses | 238,795,000USD | 167,602,000USD | 150,953,000USD | 148,760,000USD | 151,139,000USD | 155,277,000USD | 209,307,000USD | 212,483,000USD |
| Operating Income | 126,722,000USD | 108,627,000USD | 110,690,000USD | 139,091,000USD | 145,972,000USD | 115,490,000USD | 120,107,000USD | 138,297,000USD |
| Total Other Income Expense Net | -11,675,000USD | -14,856,000USD | -19,168,000USD | 15,036,000USD | -6,258,000USD | -9,475,000USD | -4,037,000USD | -7,166,000USD |
| Interest Income | 2,787,000USD | 3,642,000USD | 12,499,000USD | 2,400,000USD | 4,559,000USD | 2,814,000USD | 3,079,000USD | 3,022,000USD |
| Interest Expense | 16,001,000USD | 16,942,000USD | 17,004,000USD | 13,532,000USD | 10,850,000USD | 11,351,000USD | 11,372,000USD | 12,290,000USD |
| Income Before Tax | 115,047,000USD | 93,771,000USD | 91,522,000USD | 154,127,000USD | 139,714,000USD | 106,015,000USD | 116,070,000USD | 131,131,000USD |
| Income Tax Expense | 27,037,000USD | 21,004,000USD | 17,252,000USD | 26,295,000USD | 27,982,000USD | 27,352,000USD | 15,205,000USD | 31,209,000USD |
| Equity Method Income Loss | 1,404,000USD | — | — | — | — | — | — | — |
| Net Income | 88,010,000USD | 72,674,000USD | 74,344,000USD | 127,927,000USD | 111,720,000USD | 78,798,000USD | 100,944,000USD | 100,039,000USD |
| Net Income Applicable To Common Shares | 87,573,000USD | — | 74,344,000USD | 127,927,000USD | 111,720,000USD | 78,798,000USD | 100,944,000USD | 100,039,000USD |
| Research Development | — | 167,602,000USD | 151,321,000USD | 455,176,000USD | 306,416,000USD | 155,277,000USD | 138,512,000USD | 141,604,000USD |
| Selling General Administrative | — | 167,602,000USD | 151,321,000USD | 148,760,000USD | 151,139,000USD | 155,277,000USD | 138,512,000USD | 141,604,000USD |
| Unclassified Operating Expenses | — | -167,602,000USD | -151,689,000USD | -455,176,000USD | -306,416,000USD | -155,277,000USD | -67,717,000USD | -70,725,000USD |
| Net Interest Income | — | -13,300,000USD | -12,422,000USD | -11,132,000USD | -8,970,000USD | -8,537,000USD | -8,293,000USD | -9,268,000USD |
| Tax Provision | — | 21,004,000USD | 17,252,000USD | 26,295,000USD | 27,982,000USD | 27,352,000USD | 15,205,000USD | 31,209,000USD |
| Net Income From Continuing Ops | — | 72,767,000USD | 74,270,000USD | 127,832,000USD | 111,732,000USD | 78,663,000USD | 100,865,000USD | 99,922,000USD |
| Ebit | — | 110,713,000USD | 108,526,000USD | 167,659,000USD | 150,564,000USD | 117,366,000USD | 127,442,000USD | 143,421,000USD |
| Ebitda | — | 186,438,000USD | 185,104,000USD | 242,893,000USD | 220,468,000USD | 183,013,000USD | 194,894,000USD | 210,436,000USD |
| Depreciation And Amortization | — | 75,725,000USD | 76,578,000USD | 75,234,000USD | 69,904,000USD | 65,647,000USD | 67,452,000USD | 67,015,000USD |
| Reconciled Depreciation | — | 75,725,000USD | 76,578,000USD | 75,234,000USD | 69,904,000USD | 65,647,000USD | 67,452,000USD | 67,015,000USD |
| Minority Interest | — | -93,000USD | 74,000USD | 95,000USD | -12,000USD | 135,000USD | 79,000USD | 117,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 3,777,181,000USD | 3,582,890,000USD | 3,487,450,000USD | 3,322,249,000USD | 3,227,221,000USD | 2,929,340,000USD | 2,859,732,000USD | 2,764,761,000USD |
| Cost Of Revenue | 2,659,809,000USD | 2,227,381,000USD | 2,224,051,000USD | 2,158,411,000USD | 2,070,538,000USD | 1,842,821,000USD | 1,818,398,000USD | 1,812,961,000USD |
| Gross Profit | 1,117,372,000USD | 1,355,509,000USD | 1,263,399,000USD | 1,163,838,000USD | 1,156,683,000USD | 1,086,519,000USD | 1,041,334,000USD | 951,800,000USD |
| Research Development | 105,100,000USD | 96,100,000USD | 92,800,000USD | 544,262,000USD | 99,800,000USD | 92,500,000USD | 82,800,000USD | 75,300,000USD |
| Selling General Administrative | 606,497,000USD | 582,226,000USD | 555,399,000USD | 544,262,000USD | 551,242,000USD | 500,229,000USD | 454,617,000USD | 429,955,000USD |
| Unclassified Operating Expenses | -106,560,000USD | 180,686,000USD | 211,181,000USD | -303,959,000USD | 158,293,000USD | 154,292,000USD | 111,752,000USD | 96,447,000USD |
| Total Operating Expenses | 605,037,000USD | 859,012,000USD | 859,380,000USD | 784,565,000USD | 809,335,000USD | 747,021,000USD | 649,169,000USD | 601,702,000USD |
| Operating Income | 512,335,000USD | 496,497,000USD | 404,019,000USD | 379,273,000USD | 347,348,000USD | 339,498,000USD | 371,693,000USD | 286,269,000USD |
| Interest Income | 34,151,000USD | 12,101,000USD | 2,937,000USD | 2,700,000USD | 22,599,000USD | 958,000USD | 4,174,000USD | 7,056,000USD |
| Interest Expense | 52,737,000USD | 43,898,000USD | 40,418,000USD | 40,827,000USD | 30,284,000USD | 33,244,000USD | 35,489,000USD | 32,626,000USD |
| Net Interest Income | -41,061,000USD | -31,797,000USD | -37,122,000USD | -38,127,000USD | -26,616,000USD | -32,286,000USD | -31,315,000USD | -25,570,000USD |
| Income Before Tax | 491,378,000USD | 469,765,000USD | 374,825,000USD | 334,704,000USD | 321,655,000USD | 301,155,000USD | 342,069,000USD | 266,020,000USD |
| Income Tax Expense | 98,881,000USD | 95,587,000USD | 90,649,000USD | 95,149,000USD | 78,017,000USD | 87,065,000USD | 99,842,000USD | 71,254,000USD |
| Tax Provision | 98,881,000USD | 95,587,000USD | 86,563,000USD | 95,149,000USD | 78,017,000USD | 87,065,000USD | 99,842,000USD | 71,254,000USD |
| Net Income | 392,789,000USD | 374,541,000USD | 284,487,000USD | 239,288,000USD | 244,097,000USD | 214,040,000USD | 242,202,000USD | 194,745,000USD |
| Net Income From Continuing Ops | 392,497,000USD | 374,178,000USD | 281,325,000USD | 239,555,000USD | 243,638,000USD | 214,090,000USD | 242,227,000USD | 194,766,000USD |
| Ebit | 544,115,000USD | 513,663,000USD | 415,243,000USD | 375,702,000USD | 351,939,000USD | 335,873,000USD | 377,558,000USD | 303,822,000USD |
| Ebitda | 831,478,000USD | 777,447,000USD | 663,836,000USD | 609,408,000USD | 586,792,000USD | 556,173,000USD | 572,110,000USD | 475,569,000USD |
| Depreciation And Amortization | 287,363,000USD | 263,784,000USD | 248,593,000USD | 233,706,000USD | 234,853,000USD | 220,300,000USD | 194,552,000USD | 171,747,000USD |
| Reconciled Depreciation | 287,363,000USD | 263,784,000USD | 243,100,000USD | 233,706,000USD | 234,853,000USD | 220,300,000USD | 194,552,000USD | 171,747,000USD |
| Total Other Income Expense Net | -20,957,000USD | -26,732,000USD | -29,194,000USD | -44,569,000USD | -25,693,000USD | -38,343,000USD | -29,624,000USD | -20,249,000USD |
| Minority Interest | 292,000USD | 363,000USD | -197,000USD | -267,000USD | 459,000USD | 396,000USD | 25,000USD | 315,000USD |
| Net Income Applicable To Common Shares | 392,789,000USD | 374,541,000USD | 284,487,000USD | 239,288,000USD | 244,097,000USD | 214,040,000USD | 242,202,000USD | 194,745,000USD |
| Non Operating Income Net Other | — | — | — | — | — | — | 5,865,000USD | 12,377,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 5,133,214,000USD | 5,097,783,000USD | 5,252,719,000USD | 5,100,848,000USD | 4,865,381,000USD | 4,527,088,000USD | 4,432,278,000USD | 4,625,215,000USD |
| Cash And Equivalents | 190,402,000USD | — | 402,424,000USD | 257,057,000USD | 161,728,000USD | 125,839,000USD | 223,844,000USD | 325,524,000USD |
| Cash And Short Term Investments | 197,266,000USD | 229,477,000USD | 409,533,000USD | 264,815,000USD | 169,765,000USD | 136,821,000USD | 226,181,000USD | 327,911,000USD |
| Short Term Investments | 6,864,000USD | 6,948,000USD | 7,109,000USD | 7,758,000USD | 8,037,000USD | 10,982,000USD | 2,337,000USD | 2,387,000USD |
| Long Term Investments | 134,751,000USD | 130,761,000USD | 131,030,000USD | 130,348,000USD | 154,101,000USD | 147,686,000USD | 146,269,000USD | 51,052,000USD |
| Total Current Assets | 1,834,816,000USD | 1,768,272,000USD | 1,893,562,000USD | 1,783,602,000USD | 1,663,020,000USD | 1,511,767,000USD | 1,478,383,000USD | 1,665,604,000USD |
| Other Current Assets | 159,754,000USD | 154,045,000USD | 142,354,000USD | 172,465,000USD | 165,609,000USD | 148,723,000USD | 132,338,000USD | 150,164,000USD |
| Other Non Current Assets | 1,652,417,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 2,458,769,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 1,136,547,000USD | 1,063,033,000USD | 1,166,444,000USD | 1,499,193,000USD | 1,368,884,000USD | 1,208,024,000USD | 1,068,281,000USD | 1,026,652,000USD |
| Total Stockholder Equity | 2,628,293,000USD | 2,629,495,000USD | 2,668,096,000USD | 2,796,658,000USD | 2,700,122,000USD | 2,537,558,000USD | 2,471,888,000USD | 2,539,009,000USD |
| Total Equity Including Noncontrolling Interest | 2,674,445,000USD | — | — | — | — | — | — | — |
| Long Term Debt | 1,118,415,000USD | 1,143,370,000USD | 1,139,433,000USD | 546,016,000USD | 535,054,000USD | 561,165,000USD | 688,066,000USD | 822,731,000USD |
| Deferred Revenue | 79,525,000USD | — | — | — | — | — | — | — |
| Deferred Revenue Non Current | 36,294,000USD | — | — | — | — | — | — | — |
| Inventory | 580,136,000USD | 551,482,000USD | 537,845,000USD | 547,304,000USD | 527,421,000USD | 483,520,000USD | 461,807,000USD | 488,540,000USD |
| Property Plant Equipment Net | 1,707,017,000USD | 1,660,929,000USD | 1,742,177,000USD | 1,706,936,000USD | 1,651,613,000USD | 1,555,965,000USD | 1,511,363,000USD | 1,580,625,000USD |
| Goodwill | 1,069,666,000USD | — | — | — | — | — | — | — |
| Common Stock | 732,000USD | 731,000USD | 728,000USD | 728,000USD | 727,000USD | 726,000USD | 725,000USD | 723,000USD |
| Retained Earnings | 2,741,148,000USD | 2,684,382,000USD | 2,642,552,000USD | 2,599,697,000USD | 2,501,415,000USD | 2,419,414,000USD | 2,370,537,000USD | 2,299,540,000USD |
| Accumulated Other Comprehensive Income | -207,325,000USD | -198,716,000USD | -186,382,000USD | -207,495,000USD | -205,748,000USD | -350,858,000USD | -429,475,000USD | -308,880,000USD |
| Intangible Assets | — | 244,508,000USD | 255,339,000USD | 260,372,000USD | 249,896,000USD | 249,960,000USD | 254,769,000USD | 271,215,000USD |
| Total Liab | — | 2,423,532,000USD | 2,540,494,000USD | 2,288,780,000USD | 2,147,567,000USD | 1,975,554,000USD | 1,946,354,000USD | 2,071,574,000USD |
| Other Current Liab | — | 82,422,000USD | 407,523,000USD | 844,622,000USD | 122,840,000USD | 98,656,000USD | 369,604,000USD | 88,422,000USD |
| Capital Stock | — | 731,000USD | 728,000USD | 728,000USD | 727,000USD | 726,000USD | 725,000USD | 723,000USD |
| Good Will | — | 1,072,560,000USD | 1,077,898,000USD | 1,066,772,000USD | 996,489,000USD | 954,292,000USD | 936,256,000USD | 968,293,000USD |
| Cash | — | 222,529,000USD | 402,424,000USD | 257,057,000USD | 161,728,000USD | 125,839,000USD | 223,844,000USD | 325,524,000USD |
| Net Debt | — | 1,187,020,000USD | 1,128,480,000USD | 992,745,000USD | 974,509,000USD | 931,562,000USD | 852,223,000USD | 809,183,000USD |
| Short Term Debt | — | 222,166,000USD | 343,531,000USD | 654,571,000USD | 551,523,000USD | 445,386,000USD | 338,285,000USD | 253,112,000USD |
| Short Long Term Debt | — | 222,166,000USD | 343,531,000USD | 654,571,000USD | 551,523,000USD | 445,386,000USD | 338,285,000USD | 253,112,000USD |
| Short Long Term Debt Total | — | 1,409,549,000USD | 1,530,904,000USD | 1,249,802,000USD | 1,136,237,000USD | 1,057,401,000USD | 1,076,067,000USD | 1,134,707,000USD |
| Net Receivables | — | 833,268,000USD | 803,830,000USD | 799,018,000USD | 800,225,000USD | 742,703,000USD | 658,057,000USD | 698,989,000USD |
| Accounts Payable | — | 758,445,000USD | 340,563,000USD | 844,622,000USD | 694,521,000USD | 663,982,000USD | 295,967,000USD | 685,118,000USD |
| Property Plant Equipment Gross | — | 4,649,986,000USD | 4,641,426,000USD | 4,549,332,000USD | 4,457,614,000USD | 4,158,347,000USD | 3,987,434,000USD | 4,152,795,000USD |
| Common Stock Shares Outstanding | — | 64,834,000shares | 65,796,000shares | 66,629,999shares | 67,048,000shares | 67,491,000shares | 67,923,000shares | 67,716,000shares |
| Non Current Assets Total | — | 3,329,511,000USD | 3,359,157,000USD | 3,317,246,000USD | 3,202,361,000USD | 3,015,321,000USD | 2,953,895,000USD | 2,959,611,000USD |
| Non Current Liabilities Total | — | 1,360,499,000USD | 1,374,050,000USD | 789,587,000USD | 778,683,000USD | 767,530,000USD | 878,073,000USD | 1,044,922,000USD |
| Non Current Liabilities Other | — | 91,686,000USD | 99,432,000USD | 98,858,000USD | 100,366,000USD | 73,824,000USD | 63,822,000USD | 77,578,000USD |
| Non Currrent Assets Other | — | 220,753,000USD | 152,713,000USD | 152,818,000USD | 150,262,000USD | 107,418,000USD | 105,238,000USD | 88,426,000USD |
| Net Working Capital | — | 705,239,000USD | 727,118,000USD | 284,409,000USD | 294,136,000USD | 303,743,000USD | 410,102,000USD | 638,952,000USD |
| Unclassified Current Liabilities | — | -222,166,000USD | -343,531,000USD | -1,499,193,000USD | -551,523,000USD | -445,386,000USD | -338,285,000USD | -318,016,000USD |
| Unclassified Non Current Liabilities | — | 125,443,000USD | 135,185,000USD | 144,713,000USD | 143,263,000USD | 132,541,000USD | 126,185,000USD | 144,613,000USD |
| Unclassified Equity | — | 142,367,000USD | 210,470,000USD | 403,000,000USD | 403,001,000USD | 467,550,000USD | 529,376,000USD | 546,903,000USD |
| Other Assets | — | — | 604,780,000USD | 152,818,000USD | 621,339,000USD | 107,418,000USD | 105,238,000USD | 88,426,000USD |
| Current Deferred Revenue | — | — | 74,827,000USD | — | — | — | 64,425,000USD | 64,904,000USD |
| Unclassified Non Current Assets | — | — | -604,780,000USD | -152,818,000USD | -621,339,000USD | -107,418,000USD | -105,238,000USD | -88,426,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 5,252,719,000USD | 4,432,278,000USD | 4,451,890,000USD | 4,203,458,000USD | 4,141,364,000USD | 3,990,053,000USD | 3,562,119,000USD | 3,377,735,000USD |
| Intangible Assets | 255,339,000USD | 254,769,000USD | 283,211,000USD | 315,744,000USD | 362,343,000USD | 344,309,000USD | 291,084,000USD | 254,904,000USD |
| Other Current Assets | 142,354,000USD | 132,338,000USD | 134,761,000USD | 124,766,000USD | 121,729,000USD | 122,613,000USD | 115,048,000USD | 118,245,000USD |
| Total Liab | 2,540,494,000USD | 1,946,354,000USD | 2,130,592,000USD | 2,135,254,000USD | 2,156,764,000USD | 2,139,268,000USD | 1,989,867,000USD | 1,954,864,000USD |
| Total Stockholder Equity | 2,668,096,000USD | 2,471,888,000USD | 2,306,824,000USD | 2,053,935,000USD | 1,969,407,000USD | 1,850,389,000USD | 1,571,916,000USD | 1,422,556,000USD |
| Other Current Liab | 407,523,000USD | 369,604,000USD | 404,011,000USD | 390,629,000USD | 320,650,000USD | 331,669,000USD | 293,469,000USD | 292,896,000USD |
| Common Stock | 728,000USD | 725,000USD | 717,000USD | 709,000USD | 704,000USD | 695,000USD | 686,000USD | 673,000USD |
| Capital Stock | 728,000USD | 725,000USD | 717,000USD | 709,000USD | 704,000USD | 695,000USD | 686,000USD | 673,000USD |
| Retained Earnings | 2,642,552,000USD | 2,370,537,000USD | 2,109,816,000USD | 1,929,240,000USD | 1,789,413,000USD | 1,643,825,000USD | 1,523,820,000USD | 1,371,826,000USD |
| Good Will | 1,077,898,000USD | 936,256,000USD | 963,418,000USD | 945,632,000USD | 974,157,000USD | 898,521,000USD | 763,461,000USD | 712,095,000USD |
| Other Assets | 604,780,000USD | -1,478,383,000USD | 69,642,000USD | 57,144,000USD | 533,122,000USD | 59,548,000USD | 47,882,000USD | 62,867,000USD |
| Cash | 402,424,000USD | 223,844,000USD | 223,643,000USD | 141,732,000USD | 122,925,000USD | 300,137,000USD | 241,970,000USD | 261,823,000USD |
| Cash And Equivalents | 402,424,000USD | 223,844,000USD | 223,643,000USD | 141,732,000USD | 122,925,000USD | 300,137,000USD | 241,970,000USD | 261,823,000USD |
| Cash And Short Term Investments | 409,533,000USD | 226,181,000USD | 223,643,000USD | 141,732,000USD | 123,665,000USD | 300,380,000USD | 241,970,000USD | 261,823,000USD |
| Total Current Assets | 1,893,562,000USD | 1,478,383,000USD | 1,549,279,000USD | 1,430,291,000USD | 1,358,208,000USD | 1,368,995,000USD | 1,291,241,000USD | 1,330,808,000USD |
| Total Current Liabilities | 1,166,444,000USD | 1,068,281,000USD | 1,251,309,000USD | 917,176,000USD | 982,492,000USD | 780,329,000USD | 683,275,000USD | 689,170,000USD |
| Current Deferred Revenue | 74,827,000USD | 64,425,000USD | 60,507,000USD | 80,241,000USD | 86,953,000USD | 87,052,000USD | 86,820,000USD | 67,775,000USD |
| Net Debt | 1,128,480,000USD | 852,223,000USD | 961,032,000USD | 1,079,838,000USD | 1,121,736,000USD | 924,939,000USD | 1,009,006,000USD | 1,028,141,000USD |
| Short Term Debt | 343,531,000USD | 338,285,000USD | 458,220,000USD | 126,025,000USD | 289,627,000USD | 117,866,000USD | 110,247,000USD | 163,971,000USD |
| Short Long Term Debt | 343,531,000USD | 338,285,000USD | 458,220,000USD | 122,791,000USD | 285,883,000USD | 117,866,000USD | 110,247,000USD | 163,971,000USD |
| Short Long Term Debt Total | 1,530,904,000USD | 1,076,067,000USD | 1,184,675,000USD | 1,221,570,000USD | 1,244,661,000USD | 1,225,076,000USD | 1,250,976,000USD | 1,289,964,000USD |
| Long Term Debt | 1,139,433,000USD | 688,066,000USD | 681,188,000USD | 1,052,597,000USD | 907,024,000USD | 1,054,998,000USD | 1,085,453,000USD | 1,125,993,000USD |
| Long Term Investments | 131,030,000USD | 146,269,000USD | 49,203,000USD | 52,308,000USD | 59,485,000USD | 50,087,000USD | 8,396,000USD | 25,448,000USD |
| Short Term Investments | 7,109,000USD | 2,337,000USD | 0USD | 89,424,000USD | 740,000USD | 243,000USD | — | 259,000USD |
| Net Receivables | 803,830,000USD | 658,057,000USD | 677,822,000USD | 676,987,000USD | 671,350,000USD | 566,623,000USD | 558,428,000USD | 569,630,000USD |
| Inventory | 537,845,000USD | 461,807,000USD | 513,053,000USD | 486,806,000USD | 441,464,000USD | 379,379,000USD | 375,795,000USD | 381,110,000USD |
| Accounts Payable | 340,563,000USD | 295,967,000USD | 328,571,000USD | 320,281,000USD | 285,262,000USD | 243,742,000USD | 192,739,000USD | 164,528,000USD |
| Property Plant Equipment Net | 1,742,177,000USD | 1,511,363,000USD | 1,537,137,000USD | 1,402,339,000USD | 1,338,331,000USD | 1,268,593,000USD | 1,160,055,000USD | 991,613,000USD |
| Property Plant Equipment Gross | 4,641,426,000USD | 3,987,434,000USD | 4,021,158,000USD | 3,707,931,000USD | 3,587,929,000USD | 1,268,593,000USD | 1,160,055,000USD | 991,613,000USD |
| Accumulated Other Comprehensive Income | -186,382,000USD | -429,475,000USD | -308,734,000USD | -341,366,000USD | -316,041,000USD | -281,709,000USD | -341,948,000USD | -310,504,000USD |
| Common Stock Shares Outstanding | 66,724,999shares | 67,691,000shares | 66,905,000shares | 66,718,999shares | 67,682,000shares | 66,657,000shares | 66,150,000shares | 64,958,000shares |
| Non Current Assets Total | 3,359,157,000USD | 2,953,895,000USD | 2,902,611,000USD | 2,773,167,000USD | 2,783,156,000USD | 2,621,058,000USD | 2,270,878,000USD | 2,046,927,000USD |
| Non Current Liabilities Total | 1,374,050,000USD | 878,073,000USD | 879,283,000USD | 1,218,078,000USD | 1,174,272,000USD | 1,358,939,000USD | 1,306,592,000USD | 1,265,694,000USD |
| Non Current Liabilities Other | 99,432,000USD | 63,822,000USD | 71,017,000USD | 52,993,000USD | 74,882,000USD | 68,528,000USD | 23,250,000USD | 23,465,000USD |
| Non Currrent Assets Other | 152,713,000USD | 105,238,000USD | 69,642,000USD | 57,144,000USD | 48,840,000USD | 59,548,000USD | 47,882,000USD | 62,867,000USD |
| Net Working Capital | 727,118,000USD | 410,102,000USD | 297,970,000USD | 513,115,000USD | 375,716,000USD | 588,666,000USD | 607,966,000USD | 641,638,000USD |
| Unclassified Non Current Assets | -604,780,000USD | — | -69,642,000USD | -57,144,000USD | -533,122,000USD | -59,548,000USD | -47,882,000USD | -62,867,000USD |
| Unclassified Current Liabilities | -343,531,000USD | -338,285,000USD | -458,220,000USD | -122,791,000USD | -285,883,000USD | -117,866,000USD | -110,247,000USD | -163,971,000USD |
| Unclassified Non Current Liabilities | 135,185,000USD | 126,185,000USD | 127,078,000USD | — | -74,882,000USD | -16,316,000USD | -110,587,000USD | -139,701,000USD |
| Unclassified Equity | 210,470,000USD | 529,376,000USD | 504,308,000USD | 464,643,000USD | 915,830,000USD | 848,466,000USD | 769,910,000USD | 678,096,000USD |
| Other Liab | — | — | — | 122,533,000USD | 267,248,000USD | 251,729,000USD | 165,863,000USD | 139,701,000USD |
| Net Tangible Assets | — | — | — | 792,559,000USD | 995,250,000USD | 607,559,000USD | 1,627,192,000USD | 455,557,000USD |
| Unclassified Current Assets | — | — | — | -89,424,000USD | — | — | — | — |
| Treasury Stock | — | — | — | — | -421,203,000USD | -361,583,000USD | -381,238,000USD | -318,208,000USD |
| Deferred Long Term Liab | — | — | — | — | — | — | 142,613,000USD | 116,236,000USD |
| Accumulated Depreciation | — | — | — | — | — | — | -1,963,520,000USD | -1,855,810,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 155,366,000USD |
| Stock Based Compensation | 24,072,000USD |
| Deferred Income Tax | -3,098,000USD |
| Change To Inventory | -48,178,000USD |
| Change To Liabilities | 67,020,000USD |
| Change In Working Capital | -5,859,000USD |
| Operating Cash Flow | 222,180,000USD |
| Capital Expenditures | -122,959,000USD |
| Other Investing Activities | -156,000USD |
| Unclassified Investing Cash Flow | 1,228,000USD |
| Investing Cash Flow | -121,887,000USD |
| Net Debt Issuance | -151,784,000USD |
| Net Common Stock Issuance | -149,973,000USD |
| Common Dividends Paid | -61,531,000USD |
| Other Financing Activities | 1,112,000USD |
| Unclassified Financing Cash Flow | 53,888,000USD |
| Financing Cash Flow | -308,288,000USD |
| Effect Of Forex Changes On Cash | -4,027,000USD |
| Change In Cash | -212,022,000USD |
| End Cash Flow | 192,827,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 72,767,000USD | 74,344,000USD | 127,847,000USD | 111,732,000USD | 78,663,000USD | 100,865,000USD | 99,922,000USD | 90,458,000USD |
| Depreciation | 75,725,000USD | 76,578,000USD | 75,234,000USD | 69,904,000USD | 65,647,000USD | 67,452,000USD | 67,015,000USD | 64,968,000USD |
| Stock Based Compensation | 16,764,000USD | 7,169,000USD | 17,086,000USD | 8,015,000USD | 19,193,000USD | 9,688,000USD | 10,409,000USD | 9,277,000USD |
| Other Non Cash Items | -16,157,000USD | 13,111,000USD | -31,939,000USD | -329,000USD | 2,051,000USD | 5,181,000USD | 1,111,000USD | 2,270,000USD |
| Change To Account Receivables | -33,030,000USD | -7,076,000USD | 16,395,000USD | -13,960,000USD | -69,247,000USD | 5,975,000USD | 54,306,000USD | -21,833,000USD |
| Change To Inventory | -16,943,000USD | 12,136,000USD | -6,831,000USD | -9,908,000USD | -6,043,000USD | -752,000USD | 8,940,000USD | 6,447,000USD |
| Change In Working Capital | -25,838,000USD | -502,000USD | -93,000USD | -43,902,000USD | -80,952,000USD | 4,806,000USD | 54,319,000USD | -23,213,000USD |
| Total Cash From Operating Activities | 118,694,000USD | 183,693,000USD | 177,606,000USD | 125,958,000USD | 82,742,000USD | 178,239,000USD | 229,262,000USD | 143,579,000USD |
| Capital Expenditures | -65,396,000USD | -86,819,000USD | -63,313,000USD | -64,956,000USD | -59,337,000USD | -70,532,000USD | -79,792,000USD | -68,205,000USD |
| Free Cash Flow | 53,298,000USD | 96,874,000USD | 114,293,000USD | 61,002,000USD | 23,405,000USD | 107,707,000USD | 149,470,000USD | 75,374,000USD |
| Investments | -103,000USD | 1,551,000USD | -89,049,000USD | -69,438,000USD | -56,632,000USD | -171,065,000USD | -80,670,000USD | -68,414,000USD |
| Total Cashflows From Investing Activities | -65,099,000USD | -116,220,000USD | -88,346,000USD | -69,438,000USD | -56,632,000USD | -171,065,000USD | -80,670,000USD | -68,414,000USD |
| Net Borrowings | -115,855,000USD | 284,568,000USD | 72,455,000USD | 65,267,000USD | -28,229,000USD | -30,857,000USD | -21,163,000USD | — |
| Total Cash From Financing Activities | -230,340,000USD | 76,669,000USD | 7,112,000USD | -27,265,000USD | -134,777,000USD | -87,694,000USD | -48,641,000USD | -53,257,000USD |
| Dividends Paid | -30,920,000USD | -31,497,000USD | -29,646,000USD | -29,718,000USD | -29,923,000USD | -29,947,000USD | -29,876,000USD | -27,168,000USD |
| Sale Purchase Of Stock | -99,973,000USD | -175,000,000USD | -40,005,000USD | -70,000,000USD | -80,000,000USD | -37,335,000USD | -14,169,000USD | -5,058,000USD |
| Change In Cash | -179,895,000USD | 145,367,000USD | 95,329,000USD | 35,889,000USD | -98,005,000USD | -101,180,000USD | 104,032,000USD | 21,658,000USD |
| Begin Period Cash Flow | 404,849,000USD | 257,057,000USD | 161,728,000USD | 125,839,000USD | 223,844,000USD | 325,524,000USD | 221,492,000USD | 199,834,000USD |
| End Period Cash Flow | 224,954,000USD | 402,424,000USD | 257,057,000USD | 161,728,000USD | 125,839,000USD | 224,344,000USD | 325,524,000USD | 221,492,000USD |
| Other Cashflows From Investing Activities | 400,000USD | 3,527,000USD | 86,000USD | -4,482,000USD | 2,793,000USD | -1,478,000USD | -878,000USD | 967,000USD |
| Other Cashflows From Financing Activities | 5,151,000USD | -4,634,000USD | 4,308,000USD | 7,186,000USD | 3,375,000USD | 10,445,000USD | 16,567,000USD | 5,457,000USD |
| Unclassified Operating Cash Flow | -4,567,000USD | 12,993,000USD | -10,529,000USD | -19,462,000USD | -1,860,000USD | -9,753,000USD | -3,514,000USD | — |
| Unclassified Financing Cash Flow | 11,257,000USD | 3,232,000USD | — | — | — | — | — | -26,488,000USD |
| Unclassified Investing Cash Flow | — | -34,479,000USD | 63,930,000USD | 69,438,000USD | 56,544,000USD | 72,010,000USD | 80,670,000USD | 67,238,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 392,789,000USD | 374,178,000USD | 284,176,000USD | 239,555,000USD | 243,638,000USD | 214,090,000USD | 242,227,000USD | 194,766,000USD |
| Depreciation | 287,363,000USD | 263,784,000USD | 248,593,000USD | 233,706,000USD | 234,853,000USD | 220,300,000USD | 194,552,000USD | 171,747,000USD |
| Stock Based Compensation | 43,941,000USD | 47,650,000USD | 41,293,000USD | 40,937,000USD | 38,870,000USD | 34,148,000USD | 23,893,000USD | 19,561,000USD |
| Other Non Cash Items | 26,985,000USD | 11,467,000USD | 15,309,000USD | 21,522,000USD | 30,133,000USD | 33,473,000USD | 16,333,000USD | 13,383,000USD |
| Change To Account Receivables | -73,888,000USD | -18,079,000USD | 15,431,000USD | -27,937,000USD | -133,420,000USD | 4,286,000USD | 21,065,000USD | -66,968,000USD |
| Change To Inventory | -10,646,000USD | 21,901,000USD | -10,641,000USD | -60,354,000USD | -79,961,000USD | 13,722,000USD | 605,000USD | -25,183,000USD |
| Change In Working Capital | -125,449,000USD | -32,260,000USD | 5,751,000USD | -44,997,000USD | -169,695,000USD | 76,340,000USD | 28,706,000USD | -62,477,000USD |
| Total Cash From Operating Activities | 569,999,000USD | 643,413,000USD | 575,239,000USD | 478,617,000USD | 363,443,000USD | 570,153,000USD | 514,457,000USD | 313,628,000USD |
| Capital Expenditures | -270,419,000USD | -294,190,000USD | -318,403,000USD | -315,616,000USD | -307,935,000USD | -252,046,000USD | -247,082,000USD | -211,863,000USD |
| Free Cash Flow | 299,580,000USD | 349,223,000USD | 256,836,000USD | 163,001,000USD | 55,508,000USD | 318,107,000USD | 267,375,000USD | 101,765,000USD |
| Investments | -2,894,000USD | -396,721,000USD | -312,579,000USD | -295,642,000USD | -4,933,000USD | -451,978,000USD | -3,646,000USD | -10,779,000USD |
| Total Cashflows From Investing Activities | -330,636,000USD | -396,721,000USD | -324,463,000USD | -295,642,000USD | -457,239,000USD | -451,978,000USD | -336,268,000USD | -735,461,000USD |
| Net Borrowings | 394,061,000USD | -97,460,000USD | -51,552,000USD | 4,988,000USD | 36,951,000USD | -46,855,000USD | -111,264,000USD | 41,009,000USD |
| Total Cash From Financing Activities | -78,261,000USD | -225,344,000USD | -171,554,000USD | -162,096,000USD | -81,518,000USD | -73,723,000USD | -197,135,000USD | -14,872,000USD |
| Dividends Paid | -120,784,000USD | -114,055,000USD | -103,683,000USD | -99,461,000USD | -98,509,000USD | -92,658,000USD | -90,208,000USD | -82,346,000USD |
| Sale Purchase Of Stock | -365,005,000USD | -68,638,000USD | -47,552,000USD | -92,126,000USD | -78,148,000USD | 68,555,000USD | -86,497,000USD | -61,691,000USD |
| Change In Cash | 178,080,000USD | 201,000USD | 81,411,000USD | 19,807,000USD | -182,045,000USD | 57,997,000USD | -19,850,000USD | -445,817,000USD |
| Begin Period Cash Flow | 224,344,000USD | 224,143,000USD | 142,732,000USD | 122,925,000USD | 304,970,000USD | 246,973,000USD | 266,823,000USD | 712,640,000USD |
| End Period Cash Flow | 402,424,000USD | 224,344,000USD | 224,143,000USD | 142,732,000USD | 122,925,000USD | 304,970,000USD | 246,973,000USD | 266,823,000USD |
| Other Cashflows From Investing Activities | 3,564,000USD | -1,234,000USD | 4,906,000USD | 19,974,000USD | -1,182,000USD | -1,141,000USD | -90,346,000USD | 14,318,000USD |
| Other Cashflows From Financing Activities | -4,634,000USD | 54,809,000USD | 31,233,000USD | 333,413,000USD | -1,718,000USD | 119,984,000USD | 100,115,000USD | 88,156,000USD |
| Unclassified Operating Cash Flow | -55,630,000USD | -21,406,000USD | -19,883,000USD | -12,106,000USD | -14,356,000USD | -8,198,000USD | 8,746,000USD | -23,352,000USD |
| Unclassified Investing Cash Flow | -60,887,000USD | 295,424,000USD | 301,613,000USD | 295,642,000USD | -143,189,000USD | 253,187,000USD | 4,806,000USD | -527,137,000USD |
| Unclassified Financing Cash Flow | 18,101,000USD | — | — | -308,910,000USD | 59,906,000USD | -122,749,000USD | -9,281,000USD | — |
| Change To Liabilities | — | — | — | 55,098,000USD | 52,305,000USD | 65,592,000USD | 923,000USD | 11,238,000USD |
| Cash And Cash Equivalents Changes | — | — | — | — | — | — | -18,946,000USD | -436,705,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-06-30 | Geography | Asia | 128,411,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Geography | Europe | 521,035,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Geography | Latin America | 85,061,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Geography | North America | 292,001,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Segment | Beauty | 367,454,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Segment | Closures | 200,887,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Segment | Pharma | 458,167,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Geography | Asia | 106,245,000 | USD | 0000896622-26-000092 |
| Q1 2026Quarterly · 2026-03-31 | Geography | Europe | 510,850,000 | USD | 0000896622-26-000092 |
| Q1 2026Quarterly · 2026-03-31 | Geography | Latin America | 85,967,000 | USD | 0000896622-26-000092 |
| Q1 2026Quarterly · 2026-03-31 | Geography | North America | 279,806,000 | USD | 0000896622-26-000092 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Beauty | 363,635,000 | USD | 0000896622-26-000092 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Closures | 180,673,000 | USD | 0000896622-26-000092 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Pharma | 438,560,000 | USD | 0000896622-26-000092 |
| FY 2025Yearly · 2025-12-31 | Geography | China | 194,406,000 | USD | 0000896622-26-000007 |
| FY 2025Yearly · 2025-12-31 | Geography | ES | 195,405,000 | USD | 0000896622-26-000007 |
| FY 2025Yearly · 2025-12-31 | Geography | France | 513,281,000 | USD | 0000896622-26-000007 |
| FY 2025Yearly · 2025-12-31 | Geography | Germany | 163,913,000 | USD | 0000896622-26-000007 |
| FY 2025Yearly · 2025-12-31 | Geography | Italy | 201,895,000 | USD | 0000896622-26-000007 |
| FY 2025Yearly · 2025-12-31 | Geography | Other Europe | 824,435,000 | USD | 0000896622-26-000007 |
| FY 2025Yearly · 2025-12-31 | Geography | Other Foreign Countries | 648,786,000 | USD | 0000896622-26-000007 |
| FY 2025Yearly · 2025-12-31 | Geography | United States | 1,071,430,000 | USD | 0000896622-26-000007 |
| FY 2025Yearly · 2025-12-31 | Segment | Beauty | 1,309,437,000 | USD | 0000896622-26-000007 |
| FY 2025Yearly · 2025-12-31 | Segment | Closures | 730,263,000 | USD | 0000896622-26-000007 |
| FY 2025Yearly · 2025-12-31 | Segment | Pharma | 1,737,481,000 | USD | 0000896622-26-000007 |
| Q3 2025Quarterly · 2025-09-30 | Geography | Asia | 120,469,000 | USD | 0000896622-25-000033 |
| Q3 2025Quarterly · 2025-09-30 | Geography | Europe | 465,803,000 | USD | 0000896622-25-000033 |
| Q3 2025Quarterly · 2025-09-30 | Geography | Latin America | 75,131,000 | USD | 0000896622-25-000033 |
| Q3 2025Quarterly · 2025-09-30 | Geography | North America | 299,728,000 | USD | 0000896622-25-000033 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Aptar Beauty | 327,768,000 | USD | 0000896622-25-000033 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Aptar Closures | 187,953,000 | USD | 0000896622-25-000033 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Aptar Pharma | 445,410,000 | USD | 0000896622-25-000033 |
| Q2 2025Quarterly · 2025-06-30 | Geography | Asia | 104,123,000 | USD | 0000896622-25-000028 |
| Q2 2025Quarterly · 2025-06-30 | Geography | Europe | 475,995,000 | USD | 0000896622-25-000028 |
| Q2 2025Quarterly · 2025-06-30 | Geography | Latin America | 76,142,000 | USD | 0000896622-25-000028 |
| Q2 2025Quarterly · 2025-06-30 | Geography | North America | 309,749,000 | USD | 0000896622-25-000028 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Aptar Beauty | 334,849,000 | USD | 0000896622-25-000028 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Aptar Closures | 188,571,000 | USD | 0000896622-25-000028 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Aptar Pharma | 442,589,000 | USD | 0000896622-25-000028 |
| Q1 2025Quarterly · 2025-03-31 | Geography | Asia | 93,688,000 | USD | 0000896622-26-000092 |
| Q1 2025Quarterly · 2025-03-31 | Geography | Europe | 438,646,000 | USD | 0000896622-26-000092 |
| Q1 2025Quarterly · 2025-03-31 | Geography | Latin America | 72,514,000 | USD | 0000896622-26-000092 |
| Q1 2025Quarterly · 2025-03-31 | Geography | North America | 282,457,000 | USD | 0000896622-26-000092 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Beauty | 305,707,000 | USD | 0000896622-26-000092 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Closures | 172,131,000 | USD | 0000896622-26-000092 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Pharma | 409,467,000 | USD | 0000896622-26-000092 |
| Q4 2024Quarterly · 2024-12-31 | Segment | Aptar Beauty | 274,064,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Segment | Aptar Closures | 173,292,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Segment | Aptar Pharma | 400,732,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Geography | China | 155,502,000 | USD | 0000896622-26-000007 |
| FY 2024Yearly · 2024-12-31 | Geography | ES | 171,779,000 | USD | 0000896622-26-000007 |
| FY 2024Yearly · 2024-12-31 | Geography | France | 499,795,000 | USD | 0000896622-26-000007 |
| FY 2024Yearly · 2024-12-31 | Geography | Germany | 169,891,000 | USD | 0000896622-26-000007 |
| FY 2024Yearly · 2024-12-31 | Geography | Italy | 180,101,000 | USD | 0000896622-26-000007 |
| FY 2024Yearly · 2024-12-31 | Geography | Other Europe | 783,892,000 | USD | 0000896622-26-000007 |
| FY 2024Yearly · 2024-12-31 | Geography | Other Foreign Countries | 619,552,000 | USD | 0000896622-26-000007 |
| FY 2024Yearly · 2024-12-31 | Geography | United States | 1,037,968,000 | USD | 0000896622-26-000007 |
| FY 2024Yearly · 2024-12-31 | Segment | Beauty | 1,225,730,000 | USD | 0000896622-26-000007 |
| FY 2024Yearly · 2024-12-31 | Segment | Closures | 714,008,000 | USD | 0000896622-26-000007 |
| FY 2024Yearly · 2024-12-31 | Segment | Pharma | 1,643,152,000 | USD | 0000896622-26-000007 |
| Q3 2024Quarterly · 2024-09-30 | Geography | Asia | 103,436,000 | USD | 0000896622-25-000033 |
| Q3 2024Quarterly · 2024-09-30 | Geography | Europe | 445,129,000 | USD | 0000896622-25-000033 |
| Q3 2024Quarterly · 2024-09-30 | Geography | Latin America | 69,155,000 | USD | 0000896622-25-000033 |
| Q3 2024Quarterly · 2024-09-30 | Geography | North America | 291,571,000 | USD | 0000896622-25-000033 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Aptar Beauty | 302,859,000 | USD | 0000896622-25-000033 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Aptar Closures | 185,838,000 | USD | 0000896622-25-000033 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Aptar Pharma | 420,594,000 | USD | 0000896622-25-000033 |
| Q2 2024Quarterly · 2024-06-30 | Geography | Asia | 92,325,000 | USD | 0000896622-25-000028 |
| Q2 2024Quarterly · 2024-06-30 | Geography | Europe | 450,127,000 | USD | 0000896622-25-000028 |
| Q2 2024Quarterly · 2024-06-30 | Geography | Latin America | 77,791,000 | USD | 0000896622-25-000028 |
| Q2 2024Quarterly · 2024-06-30 | Geography | North America | 289,820,000 | USD | 0000896622-25-000028 |
| Q2 2024Quarterly · 2024-06-30 | Segment | Aptar Beauty | 321,487,000 | USD | 0000896622-25-000028 |
| Q2 2024Quarterly · 2024-06-30 | Segment | Aptar Closures | 174,043,000 | USD | 0000896622-25-000028 |
| Q2 2024Quarterly · 2024-06-30 | Segment | Aptar Pharma | 414,533,000 | USD | 0000896622-25-000028 |
| Q1 2024Quarterly · 2024-03-31 | Geography | Asia | 91,071,000 | USD | 0000896622-25-000014 |
| Q1 2024Quarterly · 2024-03-31 | Geography | Europe | 474,392,000 | USD | 0000896622-25-000014 |
| Q1 2024Quarterly · 2024-03-31 | Geography | Latin America | 72,082,000 | USD | 0000896622-25-000014 |
| Q1 2024Quarterly · 2024-03-31 | Geography | North America | 277,903,000 | USD | 0000896622-25-000014 |
| FY 2023Yearly · 2023-12-31 | Geography | China | 146,026,000 | USD | 0000896622-26-000007 |
| FY 2023Yearly · 2023-12-31 | Geography | ES | 175,101,000 | USD | 0000896622-26-000007 |
| FY 2023Yearly · 2023-12-31 | Geography | France | 541,333,000 | USD | 0000896622-26-000007 |
| FY 2023Yearly · 2023-12-31 | Geography | Germany | 160,812,000 | USD | 0000896622-26-000007 |
| FY 2023Yearly · 2023-12-31 | Geography | Italy | 200,817,000 | USD | 0000896622-26-000007 |
| FY 2023Yearly · 2023-12-31 | Geography | Other Europe | 766,373,000 | USD | 0000896622-26-000007 |
| FY 2023Yearly · 2023-12-31 | Geography | Other Foreign Countries | 586,451,000 | USD | 0000896622-26-000007 |
| FY 2023Yearly · 2023-12-31 | Geography | United States | 949,248,000 | USD | 0000896622-26-000007 |
| FY 2023Yearly · 2023-12-31 | Segment | Beauty | 1,267,697,000 | USD | 0000896622-26-000007 |
| FY 2023Yearly · 2023-12-31 | Segment | Closures | 698,760,000 | USD | 0000896622-26-000007 |
| FY 2023Yearly · 2023-12-31 | Segment | Pharma | 1,520,993,000 | USD | 0000896622-26-000007 |
| FY 2022Yearly · 2022-12-31 | Geography | China | 177,855,000 | USD | 0000896622-25-000007 |
| FY 2022Yearly · 2022-12-31 | Geography | ES | 149,987,000 | USD | 0000896622-25-000007 |
| FY 2022Yearly · 2022-12-31 | Geography | France | 487,650,000 | USD | 0000896622-25-000007 |
| FY 2022Yearly · 2022-12-31 | Geography | Germany | 163,277,000 | USD | 0000896622-25-000007 |
| FY 2022Yearly · 2022-12-31 | Geography | Italy | 149,725,000 | USD | 0000896622-25-000007 |
| FY 2022Yearly · 2022-12-31 | Geography | Other Europe | 709,810,000 | USD | 0000896622-25-000007 |
| FY 2022Yearly · 2022-12-31 | Geography | Other Foreign Countries | 555,298,000 | USD | 0000896622-25-000007 |
| FY 2022Yearly · 2022-12-31 | Geography | United States | 972,920,000 | USD | 0000896622-25-000007 |
| FY 2022Yearly · 2022-12-31 | Segment | Aptar Beauty | 1,222,535,000 | USD | 0000896622-25-000007 |
| FY 2022Yearly · 2022-12-31 | Segment | Aptar Closures | 738,458,000 | USD | 0000896622-25-000007 |
| FY 2022Yearly · 2022-12-31 | Segment | Aptar Pharma | 1,361,256,000 | USD | 0000896622-25-000007 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.